ARCHIVES

FDA carries Action On Two Cancer Drugs Over To 1996

This article is from The Cancer Letter archive.

Vol. 22 No. 01 | January 5, 1996

Download PDF Visit The Full Archive

Related Articles

Schmidt’s Doubts Threaten Control Saturation Program

August 22, 1975

In Brief Yale Cancer Center Begins Reorganization, Names New Deputy Director, Prevention Chief

January 6, 1995

NCI Advisors Approve New $5 Million Program For Reagent Contracts.

July 10, 2009

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

New Office For Protection Of Research Subjects Formed.

June 23, 2000

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994